You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

prevention of hyperkalemia in heart failure participants

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hospitalized Heart Failure With Different Serum Potassium Levels

Completed
  • Hyperkalemia
  • +2 more
    • Shanghai, Shanghai, China
      Research Site
    Aug 12, 2022

    Long-term Management of Hyperkalemia in Chronic Kidney Disease

    Recruiting
    • Hyperkalemia
      • Kasugai, Aichi, Japan
      • +25 more
      Aug 10, 2022

      Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in London (Lokelma Oral Product)

      Recruiting
      • Chronic Kidney Diseases
      • +4 more
      • Lokelma Oral Product
      • London, United Kingdom
        St Georges, University of London
      Feb 16, 2022

      Pulmonary Hypertension (World Health Organization Group 2), Heart Failure Trial (AZD3427, Placebo)

      Not yet recruiting
      • Pulmonary Hypertension (World Health Organization Group 2)
      • Heart Failure
      • (no location specified)
      Feb 17, 2023

      Heart Failure With Reduced Ejection Fraction Trial (Danicamtiv, Midazolam)

      Not yet recruiting
      • Heart Failure With Reduced Ejection Fraction
      • (no location specified)
      Jul 11, 2023

      Hyperkalemia's Illness and Treatment Burden in Chronic Kidney

      Completed
      • Hyperkalemia
        • Nagoyashi, Aichi, Japan
        • +4 more
        Sep 6, 2021

        Type 2 Diabetes in Obese, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Pioglitazone, Placebo)

        Not yet recruiting
        • Type 2 Diabetes Mellitus in Obese
        • Heart Failure With Preserved Ejection Fraction
        • San Antonio, Texas
          Texas Diabetes Institute/UH
        Apr 20, 2023

        Heart Failure Trial (PAC provision at hospital discharge, Control non-intervention; PAC without filter)

        Not yet recruiting
        • Heart Failure
        • PAC provision at hospital discharge
        • Control non-intervention; PAC without filter
        • (no location specified)
        Oct 4, 2023

        Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)

        Recruiting
        • Heart Failure
        • Hyperkalemia
        • Sodium zirconium cyclosilicate
        • Placebo
        • Gothenburg, Sweden
          Sahlgrenska University Hospital-Ostra Hospital
        Sep 20, 2021

        Hyperkalaemia and Its Impact on Therapy With RAASi

        Recruiting
        • Hyperkalaemia
        • +2 more
          • Portsmouth, United Kingdom
            Portsmouth Hospitals University NHS Trust
          Nov 10, 2022

          Breast Cancer, Myocardial Fibrosis, Radiation-Induced Fibrosis Trial in Boston (Losartan, Radiation Therapy)

          Not yet recruiting
          • Breast Cancer
          • +2 more
          • Boston, Massachusetts
            Massachusetts General Hospital Cancer Center
          Nov 1, 2022

          Type 2 Diabetes, High Blood Pressure Trial in Dallas (Polypill)

          Not yet recruiting
          • Type 2 Diabetes
          • High Blood Pressure
          • Dallas, Texas
            UT Southwestern Medical Center
          Nov 21, 2023

          Chronic Heart Failure With Reduced Ejection Fraction, Worsening Heart Failure Trial in Vadodara, Nashik (Vericiguat (Verquvo,

          Recruiting
          • Chronic Heart Failure With Reduced Ejection Fraction
          • Worsening Heart Failure
          • Vericiguat (Verquvo, BAY1021189)
          • Vadodara, Gujarat, India
          • +1 more
          Jan 16, 2023

          Cleveland Heart and Metabolic Prevention Study

          Active, not recruiting
          • Heart Failure Risk Factors in Healthy Individuals
            • Cleveland, Ohio
              Cleveland Clinic
            Sep 28, 2022

            Heart Failure With Preserved Ejection Fraction, Microvascular Dysfunction Trial in Maastricht (Participants receive 10mg

            Recruiting
            • Heart Failure With Preserved Ejection Fraction
            • Microvascular Dysfunction
            • Participants receive 10mg Empaglifozin once daily on prescription from their treating physician. This is not an intervention in this trial, but part of their normal HFpEF treatment
            • Maastricht, Limburg, Netherlands
              Maastricht University Hospital
            Sep 13, 2023

            Heart Failure With Reduced Ejection Fraction (HFrEF) Trial in Jacksonville, Saint Paul (XXB750, Placebo)

            Recruiting
            • Heart Failure With Reduced Ejection Fraction (HFrEF)
            • Jacksonville, Florida
            • +2 more
            Jan 13, 2023

            Heart Failure With Preserved Ejection Fraction Trial (Isometric exercise training)

            Not yet recruiting
            • Heart Failure With Preserved Ejection Fraction
            • Isometric exercise training
            • (no location specified)
            Oct 25, 2022

            Heart Failure, Left Ventricular Systolic Dysfunction Trial (Vericiguat tablet, Vericiguat suspension, Placebo tablet)

            Not yet recruiting
            • Heart Failure
            • Left Ventricular Systolic Dysfunction
            • Vericiguat tablet
            • +3 more
            • (no location specified)
            Jan 26, 2023

            Heart Failure, Hypertension Trial (PAL2, PHARM-PAL2)

            Not yet recruiting
            • Heart Failure
            • Hypertension
            • (no location specified)
            Nov 14, 2022

            Heart Failure Trial (Ponsegromab low dose, Ponsegromab medium dose, ponsegromab high dose)

            Not yet recruiting
            • Heart Failure
            • Ponsegromab low dose
            • +3 more
            • (no location specified)
            Aug 5, 2022

            Chronic Heart Failure Trial in Poland, United Kingdom (mRNA-0184, Placebo)

            Recruiting
            • Chronic Heart Failure
            • Wroclaw, Dolnoslaskie, Poland
            • +5 more
            Dec 13, 2022

            CHF, Renal Impairment Trial in München, Kiel (Pecavaptan (BAY1753011))

            Completed
            • Congestive Heart Failure
            • Renal Impairment
            • Pecavaptan (BAY1753011)
            • München, Bayern, Germany
            • +1 more
            Oct 26, 2022

            Heart Failure With Reduced Ejection Fraction Trial in Astrakhan (ICD implantation)

            Recruiting
            • Heart Failure With Reduced Ejection Fraction
            • ICD implantation
            • Astrakhan, Astrakhan Region, Russian Federation
              Federal Center for Cardiovascular Surgery
            Sep 13, 2022

            Heart Failure With Reduced Ejection Fraction, Acute Heart Failure Trial in Wonju (Checklist, Education, Telephone monitoring)

            Active, not recruiting
            • Heart Failure With Reduced Ejection Fraction
            • Acute Heart Failure
            • Checklist
            • +2 more
            • Wonju, Gangwon-do, Korea, Republic of
              Wonju Severance Christian Hospital,
            May 28, 2022

            Heart Failure Trial in Worldwide (BMS-986435, Placebo)

            Not yet recruiting
            • Heart Failure
            • Atlanta, Georgia
            • +40 more
            Nov 3, 2023